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B. Schneider 4, I. Eichler 2, G.L. Hall 3, J.H. Wildhaber 1 . 1Division of Respiratory 
Medicine, University Children~' Hospital Zurich, Switzerland; 2Department 
of General Paediatrics, University Children ~' hospital Medical University, 
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Aims: Cystic fibrosis (CF) lung disease is characterised byairway inflammation and 
infection. Nitrites in exhaled breath condensate (EBC-NO2) have been shown to be 
increased in children and adults with CF compared to healthy controls uggesting 
its use as a measure of airway inflammation. The aim of this longitudinal study 
was to evaluate if repeated measurements of EBC-NO 2 are helpful in monitoring 
CF lung disease activity in children. 
Methods: Thirty two children with CF (age 10.6±3.3 years) were recruited in 
the two study centres. Follow up was done longitudinally every three months 
over a period of one year with a total of five visits. At every visit clinical 
assessment including clinical scoring (modified Shwachman-Kulczycki (SK) Score) 
and a spirometry was performed. In addition an oropharyngeal swab or sputum for 
bacterial analysis was taken. EBC was sampled and analysed for NO 2 using a 
spectrophotometric assay. Furthermore at the first and the last visit a chest X-ray 
was done and scored (Chrispin-Norman (CN) Score). 
Results: There was no correlation of EBC-NO 2 and parameters of spirometry, 
SK-Score or CN-Score. Furthermore increased EBC-NO 2 levels could not predict 
pulmonary exacerbation atthe next visit. 
Conclusions: We conclude that repeated measurements of EBC-NO 2 are not helpful 
in the longitudinal monitoring of CF lung disease in children. 
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1~ Nutritional status and lung function and sputum 11-8/IL-10 levels 
in CF patients 
A. Korzeniewska 1 , J. Kaczmarek 1 , A. Soloniewicz 1 , R Stelmach 2, I. Stelmach 1 .
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Aim: This study was undertaken to define a correlation between utritional status 
and lung function and sputum I1-8/IL-10 levels in CF patients. 
Material and methods: We examined 26 clinically stable CF patients aged 6 30. 
All patients were pancreatic insuficient and chronic infected with Pseudomonas 
aeruginosa. 
Patients were matched for weight and height and BMI was calculated. FEV1 were 
measured by a spirometer (LUNGTEST 1000, MES, Kracov, Poland). Sputum IL-8 
and I1-10 levels were measured by using ELISA kits (I1-8: Bender MedSystems, Vi- 
enna, Austria and IL-10: R&D Systems, Minneapolis, USA); results were expressed 
as pg/dl. 
P-values <0.05 were considered to be significant. 
Results: Mean BMI was (mean±SD) 16.2±2.7kg/m 2 and mean FEV1 was 
64.2±25.6% of predicted value. Mean sputum IL-8 and IL-10 levels were 
587.7±350.8 pg/dl and 10.2±3.1 pg/dl respectively. There was significant correla- 
tion between BMI and FEV1 (p 0.027). We found significant inverse correlation 
between FEV1 and sputum IL-8 levels (p 0.024) and high levels of IL-10 were 
significantly correlated with increased FEV1 (p 0.021). High levels of IL-8 were 
significantly correlated with decreased BMI (p < 0.001) We found no significant 
correlation between IL-10 levels and BMI. 
Conclusions: The impaired cytokine profile observed in CF patients could be 
related to impaired nutrition and lung function. 
These data suggest a pathophysiological mechanism by which chronic pulmonary 
infection and infalmmation are connected with poor nutritional status in patients 
with cystic fibrosis. 
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Introduction: Routine care of patients with cystic fibrosis (CF) includes microbi- 
ological assessment of sputum samples at least every 3 months, but the laboratory 
at Heartlands Hospital has frequently received samples within 7 days of a previous 
sample from the same patient. To reduce the workload the laboratory has recently 
stopped processing such samples. 
Aims: We audited all sputum samples processed uring the 12 month period 
preceding the institution of this policy to assess the extent to which samples 
received within 7 days of previous amples contributed any new clinically relevant 
information. 
Methods: The sputum samples received from patients with CF during a 12 month 
period were investigated and all samples ent within 7 days of a previous ample 
were examined to identify any new organisms isolated and any changes in the 
resistance profile of Pseudomonas eruginosa. 
Results: 2216 samples from 244 patients were investigated. 517 (23%) of the 
samples were sent within 7 days of a previous ample. These originated from 112 pa- 
tients who had significantly more severe disease than the remaining 132 patients. 
The 517 samples only identified 29 new organisms, of which only 6 (1.1%) were 
thought o be potentially clinically relevant. The mean number of antimicrobials to
which P aeruginosa isolates in these samples had become newly resistant was 0.8 
(SD 1.3). 
Conclusions: There is little evidence that sputum samples ent within 7 days of 
previous amples provide enough clinically relevant information to warrant the time 
and financial cost (about £14,500 per year) to the laboratory in processing them. 
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Introduction: Leptin is an adipocyte derived hormone and important for regulation 
of energy and nutritial status. There is evidence that leptin is also involved in 
respiratory regulation in chronic pulmonary disease. 
CF patients uffer beside the pulmonary problems from a poor nutritial status and 
low body fat. We hypothyse that leptin levels would be lower in CF than in a healthy 
control group and there might be a correlation to lung function. 
Methods: Leptin levels were measured (enzyme-linked immunosorbent assay) in 
25 CF patients (14 male, 11 female) and in 30 healthy people as control group 
(10 male, 20 female). BMI and percent body fat was measured (DPX). Lung 
function was tested in all patients and in the control group (Body plethysmography 
or spirometry). 
Results: There was no difference between the groups in age, BMI and percent 
body fat. Leptin levels were similar in both groups (CF 5.22 gg/1 ± 4.5, controls 
6.58 gg/1 ± 4.5). 
There was a positive correlation of leptin and percent body fat in both groups (CF 
r 0.89, p < 0.01, controls r 0.82, p < 0.01). Leptin levels in females (CF 8.28 gg/1 
± 4.75 and controls 8.1 gg/1 ± 3.9) were higher than in males (CF 2.88 gg/1 ± 1.75, 
p 0.005, and controls 2.98 gg/1 ± 1.2, p 0.001) due to higher percent body fat 
(CF female 26.96% ± 6.6, CF male 15.5% ± 9.01, p 0.004, control female 25.49% 
± 4.77, control male 18.14% ± 6.77, p 0.002). 
There was no significant correlation to parameters of lung function in CF patients. 
Discussion: The correlation of percent body fat and leptin levels were confirmed in 
this study. A significant difference in leptin levels between CF patients and controls 
with similar body fat could not be demonstrated. Percent body fat seems to be the 
important factor in leptin regulation. There is no evidence of disturbance of the 
leptin regulation in CF due to pulmonary situation. 
